Literature DB >> 21684166

Bendigoles D-F, bioactive sterols from the marine sponge-derived Actinomadura sp. SBMs009.

Luke Simmons1, Katrin Kaufmann, Ronald Garcia, Gertrud Schwär, Volker Huch, Rolf Müller.   

Abstract

Marine derived actinomycetes have become an important source of bioactive natural products. Here we report the structure and bioactivity of the bendigoles D-F (1-3), 3-keto sterols isolated from the new marine sponge derived bacterium, Actinomadura sp. SBMs009. The isolation of these compounds was guided by a novel high-content screen for NF-κB and glucocorticoid receptor (GR) activity, and cytotoxicity assays. The structures of 1-3 were determined by detailed analysis of NMR, MS, and single crystal X-ray diffraction data. Interestingly, 1 displayed cytotoxicity against the L929 (mouse fibroblast) cell line with an IC(50) approximated to 30 μM and was the most active inhibitor of GR-translocation, while 3 was the most effective inhibitor of NF-κB nuclear translocation with an IC(50) of 71 μM.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684166     DOI: 10.1016/j.bmc.2011.05.044

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Genomic insight into a novel actinobacterium, Actinomadura rubrisoli sp. nov., reveals high potential for bioactive metabolites.

Authors:  Hilal Ay
Journal:  Antonie Van Leeuwenhoek       Date:  2021-01-15       Impact factor: 2.271

2.  Actinomadura decatromicini sp. nov., isolated from mountain soil in Thailand.

Authors:  Apakorn Songsumanus; Nattakorn Kuncharoen; Takuji Kudo; Masahiro Yuki; Moriya Ohkuma; Yasuhiro Igarashi; Somboon Tanasupawat
Journal:  J Antibiot (Tokyo)       Date:  2020-07-28       Impact factor: 2.649

3.  Structural Reassignment and Absolute Stereochemistry of Madurastatin C1 (MBJ-0034) and the Related Aziridine Siderophores: Madurastatins A1, B1, and MBJ-0035.

Authors:  Andrew R Tyler; Hamed Mosaei; Stephanie Morton; Paul G Waddell; Corinne Wills; William McFarlane; Joe Gray; Michael Goodfellow; Jeff Errington; Nick Allenby; Nikolay Zenkin; Michael J Hall
Journal:  J Nat Prod       Date:  2017-04-11       Impact factor: 4.050

Review 4.  The secondary metabolites of rare actinomycetes: chemistry and bioactivity.

Authors:  Ting Ding; Luo-Jie Yang; Wei-Dong Zhang; Yun-Heng Shen
Journal:  RSC Adv       Date:  2019-07-16       Impact factor: 4.036

Review 5.  Marine Rare Actinobacteria: Isolation, Characterization, and Strategies for Harnessing Bioactive Compounds.

Authors:  Dipesh Dhakal; Anaya Raj Pokhrel; Biplav Shrestha; Jae Kyung Sohng
Journal:  Front Microbiol       Date:  2017-06-15       Impact factor: 5.640

Review 6.  Cytotoxic Natural Products from Marine Sponge-Derived Microorganisms.

Authors:  Huawei Zhang; Ziping Zhao; Hong Wang
Journal:  Mar Drugs       Date:  2017-03-10       Impact factor: 5.118

7.  New Pim-1 Kinase Inhibitor From the Co-culture of Two Sponge-Associated Actinomycetes.

Authors:  Seham S El-Hawary; Ahmed M Sayed; Rabab Mohammed; Mohammad A Khanfar; Mostafa E Rateb; Tarek A Mohammed; Dina Hajjar; Hossam M Hassan; Tobias A M Gulder; Usama Ramadan Abdelmohsen
Journal:  Front Chem       Date:  2018-11-15       Impact factor: 5.221

Review 8.  Natural Products from Actinomycetes Associated with Marine Organisms.

Authors:  Jianing Chen; Lin Xu; Yanrong Zhou; Bingnan Han
Journal:  Mar Drugs       Date:  2021-11-10       Impact factor: 5.118

Review 9.  Targeting nuclear receptors with marine natural products.

Authors:  Chunyan Yang; Qianrong Li; Yong Li
Journal:  Mar Drugs       Date:  2014-01-27       Impact factor: 5.118

10.  Isolation of Petrocidin A, a New Cytotoxic Cyclic Dipeptide from the Marine Sponge-Derived Bacterium Streptomyces sp. SBT348.

Authors:  Cheng Cheng; Eman M Othman; Helga Stopper; RuAngelie Edrada-Ebel; Ute Hentschel; Usama Ramadan Abdelmohsen
Journal:  Mar Drugs       Date:  2017-12-06       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.